Correlation Between Xinhua Winshare and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both Xinhua Winshare and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xinhua Winshare and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xinhua Winshare Publishing and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Xinhua Winshare and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xinhua Winshare with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xinhua Winshare and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Xinhua Winshare and SCANDMEDICAL SOLDK-040

0.31

Correlation Coefficient

Xinhua Winshare  SCANDMEDICAL SOLDK-040

Weak diversification

The 3 months correlation between Xinhua and SCANDMEDICAL is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Xinhua Winshare Publishing and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Xinhua Winshare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xinhua Winshare Publishing are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Xinhua Winshare i.e., Xinhua Winshare and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Xinhua Winshare and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Xinhua Winshare Publishing is expected to generate 0.63 times more return on investment than SCANDMEDICAL SOLDK-040. However, Xinhua Winshare Publishing is 1.59 times less risky than SCANDMEDICAL SOLDK-040. It trades about -0.1 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.11 per unit of risk. If you would invest  144.00  in Xinhua Winshare Publishing on December 29, 2024 and sell it today you would lose (20.00) from holding Xinhua Winshare Publishing or give up 13.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Xinhua Winshare Publishing  vs.  SCANDMEDICAL SOLDK 040

Xinhua Winshare Publ

Risk-Adjusted Performance

Very Weak

Over the last 90 days Xinhua Winshare Publishing has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Xinhua Winshare and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Xinhua Winshare and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xinhua Winshare position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind Xinhua Winshare Publishing and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.